P Belitsky

2.7k total citations
99 papers, 2.1k citations indexed

About

P Belitsky is a scholar working on Transplantation, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, P Belitsky has authored 99 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Transplantation, 36 papers in Surgery and 27 papers in Public Health, Environmental and Occupational Health. Recurrent topics in P Belitsky's work include Renal Transplantation Outcomes and Treatments (52 papers), Organ Transplantation Techniques and Outcomes (25 papers) and Organ Donation and Transplantation (23 papers). P Belitsky is often cited by papers focused on Renal Transplantation Outcomes and Treatments (52 papers), Organ Transplantation Techniques and Outcomes (25 papers) and Organ Donation and Transplantation (23 papers). P Belitsky collaborates with scholars based in Canada, United States and Germany. P Belitsky's co-authors include Joseph Lawen, Allan S. MacDonald, Bryce Kiberd, Albert D. Fraser, Kamran Mahalati, Vivian C. McAlister, B. Kiberd, Kenneth A. West, Uğur Sungurtekin and A. S. Macdonald and has published in prestigious journals such as New England Journal of Medicine, JAMA and JNCI Journal of the National Cancer Institute.

In The Last Decade

P Belitsky

98 papers receiving 1.9k citations

Peers

Countries citing papers authored by P Belitsky

Since Specialization

Citations

This map shows the geographic impact of P Belitsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Belitsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Belitsky more than expected).

Fields of papers citing papers by P Belitsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Belitsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Belitsky. The network helps show where P Belitsky may publish in the future.

Co-authorship network of co-authors of P Belitsky

This figure shows the co-authorship network connecting the top 25 collaborators of P Belitsky. A scholar is included among the top collaborators of P Belitsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Belitsky. P Belitsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Early Adequate Mycophenolic Acid Exposure is Associated with Less Rejection in Kidney Transplantation 2004 ·American Journal of Transplantation ·Bryce Kiberd, Joseph Lawen, Albert D. Fraser, Tammy Keough-Ryan, P Belitsky	109
2	Importance of peak PRA in predicting the kidney transplant survival in highly sensitized patients 2003 ·Transplantation Proceedings ·Dharmendra Singh, B. Kiberd, Kenneth A. West, (unknown), (unknown), P Belitsky, Joseph Lawen	20
3	Approaching the Therapeutic Window for Cyclosporine in Kidney Transplantation 2001 ·Journal of the American Society of Nephrology ·Kamran Mahalati, P Belitsky, Kenneth A. West, Bryce Kiberd, Albert D. Fraser, Ingrid Sketris, A. S. Macdonald, Vivian C. McAlister, Joseph Lawen	142
4	IS ROUTINE URETERIC STENTING NEEDED IN KIDNEY TRANSPLANTATION? A RANDOMIZED TRIAL 2000 ·Transplantation ·Javier Domínguez, Catherine M. Clase, Kamran Mahalati, Allan S. MacDonald, Vivian C. McAlister, P Belitsky, Bryce Kiberd, Joseph Lawen	138
5	Effect of recipient sensitization (peak PRA) on graft outcome in haploidentical living related kidney transplants 2000 ·Clinical Transplantation ·Azemi Barama, (unknown), R. Panek, P Belitsky, (unknown), Joseph Lawen, Vivian C. McAlister, B. Kiberd	34
6	A 3-hour postdose cyclosporine level during the first week after kidney transplantation predicts acute rejection and cyclosporine nephrotoxicity more accurately than trough levels 2000 ·Transplantation Proceedings ·Kamran Mahalati, P Belitsky, Kenneth A. West, B. Kiberd, A. S. Macdonald, Vivian C. McAlister, Joseph Lawen	8
7	Impact of Absorption Profiling on Efficacy and Safety of Cyclosporin Therapy in Transplant Recipients 2000 ·Clinical Pharmacokinetics ·P Belitsky, Stephen P. Dunn, A. E. Johnston, Gary Levy	89
8	Alloimmune Thrombocytopenia after Organ Transplantation 1999 ·New England Journal of Medicine ·Kenneth A. West, David R. Anderson, Vivian C. McAlister, (unknown), P Belitsky, (unknown), John G. Kelton	34
9	Influence of drug formulation on utilization and outcomes: Neoral and monitoring by sparse sample area under the curve 1999 ·Transplantation Proceedings ·P Belitsky, Kamran Mahalati, Kenneth A. West, Ingrid Sketris	9
10	Financial impact of cold ischemia time in renal transplantation 1997 ·Transplantation Proceedings ·Azemi Barama, B. Kiberd, P Belitsky, A. S. Macdonald, H Bitter-Suermann, Kenneth A. West, Joseph Lawen, Vivian C. McAlister	7
11	Effect of Calcium-Channel Blockers on Cyclosporine Clearance and Use in Renal Transplant Patients 1994 ·Annals of Pharmacotherapy ·Ingrid Sketris, (unknown), (unknown), P Belitsky, (unknown)	30
12	FATE OF RENAL ALLOGRAFTS TRANSPLANTED IN PATIENTS WITH URINARY DIVERSION 1993 ·Transplantation ·David A. Hatch, P Belitsky, John M. Barry, Andrew C. Novick, Rodney J. Taylor, Mark L. Jordan, Arthur I. Sagalowsky, Mark R. Zaontz	42
13	A Randomized Double‐Blind Placebo Controlled Trial of Oral Acyclovir in Renal Allograft Recipients 1992 ·Canadian Journal of Infectious Diseases and Medical Microbiology ·Walter F. Schlech, (unknown), (unknown), P Belitsky, Alastair Macdonald, John C. LeBlanc	5
14	Inhibition of human renal cancer by monoclonal antibody targeted methotrexate-containing liposomes in an ascites tumor model 1991 ·Cancer Letters ·Mahendra Pratap Singh, T. Ghose, Michael Mezei, P Belitsky	27
15	Sequential discontinuation of azathioprine and prednisone in renal transplantation. 1991 ·PubMed ·(unknown), Uğur Sungurtekin, (unknown), P Belitsky, H Bitter-Suermann, (unknown), Kailash Jindal	5
16	Inhibition of human renal cancer by monoclonal-anti-body-linked methotrexate in an ascites tumor model 1991 ·Cancer Immunology Immunotherapy ·Mandip Singh, T. Ghose, Jaroslav A. Kralovec, A. H. Blair, P Belitsky	9
17	Fine-Needle Aspiration Biopsy Sampling in Renal Transplantation: Interstitial Cellular Infiltrates and Major Histocompatibility Complex Class-II Antigen Expression in Renal Tubular Cells 1989 ·Urologia Internationalis ·(unknown), P Belitsky, Rekha Gupta	2
18	RENAL TRANSPLANTATION IN SECONDARY OXALOSIS 1988 ·Transplantation ·Robin Roberts, Ingrid Sketris, A. S. Macdonald, P Belitsky	9
19	Radionuclide Imaging of Metastases from Renal-Cell Carcinoma by¹³¹I-labeled Antitumor Antibody 1978 ·Radiology ·P Belitsky, Tarun K. Ghose, José Luís Braga de Aquino, Joseph Tai, A. S. Macdonald	24
20	Preventable problems with arteriovenous fistulas for hemodialysis. 1971 ·PubMed ·(unknown), P Belitsky, (unknown), (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact